Microglia
Microglia are immune cells of the central nervous system that monitor neural tissue and respond to injury, infection, and other pathological signals.
Microglia are immune cells of the central nervous system that monitor neural tissue and respond to injury, infection, and other pathological signals. Their activation can alter inflammatory signaling, phagocytosis, apoptosis, and tissue repair. Current research links microglial responses to neuroinflammation in neuropathic pain, ischemic stroke, intracerebral hemorrhage, Alzheimer’s disease, and postoperative delirium, with associated changes examined in the brain, hippocampus, and spinal dorsal horn. Microglial signaling is studied alongside astrocytes, neurons, the blood–brain barrier, reactive oxygen species, interleukin-1β (IL-1β), and the NLRP3 inflammasome.
Microglia are also being investigated as therapeutic targets and biomarkers. Experimental approaches aim to regulate their functional states through pathways involving Nrf2/NLRP3, CXCL16, mitophagy, ADA-dependent adenosine metabolism, and staged control of oxidative stress and inflammation; reported delivery systems include ROS-responsive hydrogels and nanozymes. Transcriptomic analyses of microglial phagocytosis and live human brain multi-omics have been used to identify disease-associated molecular signatures, while hematopoietic stem cell transplantation research examines the engraftment of stem-cell progeny as microglia-like cells. These findings support microglial modulation as a potential strategy for limiting tissue damage and promoting neurorepair, although the mechanisms and diagnostic value of distinct microglial states remain under investigation.
Where the papers sit
11 papers from the last 6 months study microglia directly · updated from PubMed 12 Nov 2026
Study type 0 clinical trials · 1 human data · 8 preclinical · 2 unclassified
Themes 3 themes
-
Neuroinflammation and Brain Repair
Antioxidant and immunomodulatory strategies are being pushed toward coordinated neurorepair after ischemic, hemorrhagic, infectious, and degenerative injury. ROS-responsive hydrogels and HA@Que-Mn nanozymes aim to control oxidative stress locally, while Donepezil-associated mitophagy and CXCL16-driven phenotype changes target inflammatory damage. Blood–brain barrier injury, apoptosis, and inflammatory cell states recur as endpoints. Whether these multitarget approaches translate across diseases remains open.
4 papers · 36.4%
-
Microglial States and Toxicity
Microglial heterogeneity is increasingly being resolved with single-cell proteomics and live human brain multi-omics rather than bulk inflammatory markers. Aging-associated phagocytic subpopulations, post-operative delirium signatures, and particle-induced cytotoxicity are being mapped alongside stem-cell-derived microglia-like cells for translational modeling. Surface chemistry is a recurring determinant of silica toxicity, whereas age and tissue context shape immune states. The field is still defining how faithfully engineered or cultured cells reproduce human brain microglia.
4 papers · 36.4%
-
Microglial Immune Signatures
Microglial activation is being linked to neuropathic pain mechanisms and to disease-associated phagocytic signatures in Alzheimer’s disease. In pain models, daphnetin acts through Nrf2/NLRP3 signaling, while sacral nerve modulation targets the spinal immune microenvironment rather than neurons alone. Alzheimer’s analyses shift the emphasis toward phagocytosis markers and immune-landscape stratification. Whether these molecular signatures can guide diagnosis or treatment beyond experimental models remains unresolved.
3 papers · 27.3%
Papers
The 11 papers from the last 6 months that study microglia directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Neuroinflammation and Brain Repair (4)
- Ultrasound-Programmable ROS-Responsive Hydrogel Orchestrates Staged Immunomodulation and Neurorepair after Intracerebral Hemorrhage. ACS applied materials & interfaces · 31 Aug 2026 PMID 42673943
- Recombinant CXCL16 reduces brain injury by modulating microglial phenotype and attenuating apoptosis in acute ischemic stroke. Scientific reports · 22 Aug 2026 PMID 42632854
- Targeted HA@Que-Mn nanozymes alleviate postherpetic neuralgia by modulating neuroinflammation. Materials today. Bio · 28 Jul 2026 PMID 42518690
- A Multitarget Nanosystem Loaded with Donepezil for Alzheimer's Disease Treatment by Activating Mitophagy and Reshaping the Inflammatory Microenvironment. ACS applied materials & interfaces · 13 Jul 2026 PMID 42441421
Microglial States and Toxicity (4)
- Neuroinflammation as molecular landscape of post-operative delirium revealed by live human brain multi-omics profiling. Molecular psychiatry · 5 Aug 2026 PMID 42557393
- Cytotoxicity of silica micro/nano particles with amine surface modifications to 6-3 murine microglial cell line. Toxicology · 19 Jun 2026 PMID 42320586
- Characterization of hematopoietic stem cell-derived microglia-like cells in nonhuman primates. Blood advances · 18 Jun 2026 PMID 42314036
- Single-cell proteome atlas of aging mouse microglia reveals subpopulation-specific phagoproteome. Neuron · 11 Jun 2026 PMID 42276056
Microglial Immune Signatures (3)
- Sacral Nerve Modulation Alleviates Neuropathic Pelvic Pain Through Modulation of the Spinal Immune Microenvironment and Microglial Activation. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 16 Sept 2026 PMID 42747734
- Transcriptomic Signatures of Microglial Phagocytosis Reveal Diagnostic Markers and Immune Landscape in Alzheimer's Disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 28 Aug 2026 PMID 42663999
- Daphnetin alleviates neuropathic pain in rats by modulating spinal microglial polarization via the Nrf2/NLRP3 inflammasome pathway. International immunopharmacology · 17 Jun 2026 PMID 42308799
By study type
Human data, design not indexed (1)
- Transcriptomic Signatures of Microglial Phagocytosis Reveal Diagnostic Markers and Immune Landscape in Alzheimer's Disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 28 Aug 2026 PMID 42663999
Preclinical: animal, cell and lab studies (8)
- Sacral Nerve Modulation Alleviates Neuropathic Pelvic Pain Through Modulation of the Spinal Immune Microenvironment and Microglial Activation. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 16 Sept 2026 PMID 42747734
- Ultrasound-Programmable ROS-Responsive Hydrogel Orchestrates Staged Immunomodulation and Neurorepair after Intracerebral Hemorrhage. ACS applied materials & interfaces · 31 Aug 2026 PMID 42673943
- Recombinant CXCL16 reduces brain injury by modulating microglial phenotype and attenuating apoptosis in acute ischemic stroke. Scientific reports · 22 Aug 2026 PMID 42632854
- A Multitarget Nanosystem Loaded with Donepezil for Alzheimer's Disease Treatment by Activating Mitophagy and Reshaping the Inflammatory Microenvironment. ACS applied materials & interfaces · 13 Jul 2026 PMID 42441421
- Cytotoxicity of silica micro/nano particles with amine surface modifications to 6-3 murine microglial cell line. Toxicology · 19 Jun 2026 PMID 42320586
- Characterization of hematopoietic stem cell-derived microglia-like cells in nonhuman primates. Blood advances · 18 Jun 2026 PMID 42314036
- Daphnetin alleviates neuropathic pain in rats by modulating spinal microglial polarization via the Nrf2/NLRP3 inflammasome pathway. International immunopharmacology · 17 Jun 2026 PMID 42308799
- Single-cell proteome atlas of aging mouse microglia reveals subpopulation-specific phagoproteome. Neuron · 11 Jun 2026 PMID 42276056
Unclassified: not yet indexed with MeSH (2)
- Neuroinflammation as molecular landscape of post-operative delirium revealed by live human brain multi-omics profiling. Molecular psychiatry · 5 Aug 2026 PMID 42557393
- Targeted HA@Que-Mn nanozymes alleviate postherpetic neuralgia by modulating neuroinflammation. Materials today. Bio · 28 Jul 2026 PMID 42518690
Written from 11 PubMed abstracts, each one listed by PMID above. Published: 2026-10-15. Drafted by language models from published abstracts; not medical advice.